Advanstar for sale

Share this article:

Advanstar, the largest commercial medical publisher in the U.S., is up for sale.

Well, maybe.

After earlier dismissing talk of a sale as "highly speculative" "market rumors," the business publishing powerhouse today released a statement saying it is "exploring strategic alternatives, including a possible sale of the company," but cautioning that "there can be no assurance that the exploration of strategic alternatives will lead to a transaction."

The sale, first reported in Sunday's New York Post, follows that of six Advanstar divisions to Questex in April for $185 million. The firm, which now holds Life Sciences, Fashion and Powersports portfolios, divested its IT & Communications, Travel & Hospitality, Beauty, Home Entertainment, Abilities and Portfolio groups in the April sale.     

Advanstar's owner, Credit Suisse First Boston, declined comment.

Share this article:
You must be a registered member of MMM to post a comment.

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.